NCT06908356 - An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 10, 2025

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions

Focal Onset SeizurePrimary Generalized Epilepsy

Interventions

DRUG

30mg PRAX-628

Once daily oral

Trial Locations (11)

10941

RECRUITING

Praxis Research Site, Middletown

20817

RECRUITING

Praxis Research Site, Bethesda

28010

RECRUITING

Praxis Research Site, Madrid

30116

RECRUITING

Praxis Research Site, Miami Lakes

63005

RECRUITING

Praxis Research Site, Chesterfield

77586

RECRUITING

Praxis Research Site, Seabrook

78681

RECRUITING

Praxis Research Site, Round Rock

85032

RECRUITING

Praxis Research Site, Phoenix

07601

RECRUITING

Praxis Research Site, Hackensack

03084

RECRUITING

Praxis Research Site, Heidelberg

03004

RECRUITING

Praxis Research Site, Melbourne